About
Contact & Profiles
A5086153535
Research Areas
- Systemic Lupus Erythematosus Research
- T-cell and B-cell Immunology
- Cancer Immunotherapy and Biomarkers
- SARS-CoV-2 and COVID-19 Research
- CAR-T cell therapy research
- Rheumatoid Arthritis Research and Therapies
- Dermatological and COVID-19 studies
- interferon and immune responses
- Monoclonal and Polyclonal Antibodies Research
- Cytokine Signaling Pathways and Interactions
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Immunotherapy and Immune Responses
Brigham and Women's Hospital
2022-2025
Harvard University
2023-2024
10.1038/s41586-024-07627-2
article
EN
Nature
2024-07-10
Immune checkpoint inhibitor (ICI) therapies used to treat cancer, such as anti–PD-1 antibodies, can induce autoimmune conditions in some individuals. The T cell mechanisms mediating iatrogenic autoimmunity and their overlap with spontaneous diseases remain unclear. Here, we compared cells from the joints of 20 patients an inflammatory arthritis induced by ICI therapy (ICI-arthritis) two archetypal arthritides, rheumatoid (RA) psoriatic (PsA). Single-cell transcriptomic antigen receptor...
10.1126/sciimmunol.add1591
article
EN
Science Immunology
2023-07-28
10.1016/j.xpro.2024.103541
article
EN
STAR Protocols
2025-01-05
10.1016/j.jaut.2024.103299
article
EN
Journal of Autoimmunity
2024-08-02
10.1016/j.semarthrit.2023.152177
article
EN
publisher-specific-oa
Seminars in Arthritis and Rheumatism
2023-02-10
Coming Soon ...